AC Immune SA (ACIU)

AI-Powered SEC Filing Analysis

Insider Trading Filed: 2026-04-16

Key Insights

  • The CEO of AC Immune SA, Andrea Pfeifer, has purchased 10,000 shares of the company's stock at an average price of $3.1425 per share, indicating confidence in the company's future performance.
  • Pfeifer's total beneficial ownership has increased to 3,830,288 shares, including 1,921,005 shares underlying restricted share units, suggesting a significant stake in the company.
  • The transaction was executed pursuant to a trading plan, which may indicate a pre-planned strategy for insider buying and could signal positive long-term expectations for the stock.
Filing tone (AI): Positive
View Original Filing →

Filings on this page are at least 90 days old. In the app, any new AC Immune SA filing is analysed the moment you open it.

Download on theApp Store Get it onGoogle Play

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.